WestPark Capital Announces Completion of $4.19 Million Registered Direct Offering for Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT)
LOS ANGELES--(BUSINESS WIRE)--Mar 2, 2021-- |!| Keokuk
LOS ANGELES--(BUSINESS WIRE)--Mar 2, 2021-- |!| Keokuk